Publications by authors named "Virginia Kwitkowski"

Claim this Profile
O
Older adults in hematologic malignancy trials: Representation, barriers to participation and strategies for addressing underrepresentation.
Bindu Kanapuru, Harpreet Singh, Virginia Kwitkowski, Gideon Blumenthal, Ann T Farrell

Blood Rev· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease.
Bellinda L King-Kallimanis, Tanya Wroblewski, Virginia Kwitkowski, R Angelo De Claro, Thomas Gwise

Qual Life Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim-Chester Disease with the V600 Mutation.
Patricia A Oneal, Virginia Kwitkowski, Lola Luo, Yuan Li Shen, Sriram Subramaniam

Oncologist· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
U.S. Food and Drug Administration approval summary: Eltrombopag for the treatment of pediatric patients with chronic immune (idiopathic) thrombocytopenia.
Lori A Ehrlich, Virginia E Kwitkowski, Gregory Reaman, Chia-Wen Ko, Lei Nie

Pediatr Blood Cancer· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary on Heath et al.
Virginia Kwitkowski, Selena Daniels, Gregory Reaman, Ann Farrell, Paul Kluetz

Clin Trials· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a harmonized patient-reported outcome questionnaire to assess myelofibrosis symptoms in clinical trials.
Chad Gwaltney, Jean Paty, Virginia E Kwitkowski, Ruben A Mesa, Amylou C Dueck

Leuk Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials-Response.
Paul G Kluetz, Elektra J Papadopoulos, Laura Lee Johnson, Martha Donoghue, Virginia E Kwitkowski

Clin Cancer Res· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials: Symptomatic Adverse Events, Physical Function, and Disease-Related Symptoms.
Paul G Kluetz, Ashley Slagle, Elektra J Papadopoulos, Laura Lee Johnson, Martha Donoghue, Virginia E Kwitkowski

Clin Cancer Res· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma.
Hyon-Zu Lee, Virginia E Kwitkowski, Pedro L Del Valle, M Stacey Ricci, Haleh Saber

Clin Cancer Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
U.S. Food and drug administration approval: obinutuzumab in combination with chlorambucil for the treatment of previously untreated chronic lymphocytic leukemia.
Hyon-Zu Lee, Barry W Miller, Virginia E Kwitkowski, Stacey Ricci, Pedro DelValle

Clin Cancer Res· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain palliation measurement in cancer clinical trials: the US Food and Drug Administration perspective.
Ethan Basch, Ann Marie Trentacosti, Laurie B Burke, Virginia Kwitkowski, Robert C Kane

Cancer· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
U.S. Food and Drug Administration approval summary: omacetaxine mepesuccinate as treatment for chronic myeloid leukemia.
Firoozeh Alvandi, Virginia E Kwitkowski, Chia-Wen Ko, Mark D Rothmann, Stacey Ricci

Oncologist· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
U.S. Food and Drug Administration approval summary: brentuximab vedotin for the treatment of relapsed Hodgkin lymphoma or relapsed systemic anaplastic large-cell lymphoma.
R Angelo de Claro, Karen McGinn, Virginia Kwitkowski, Julie Bullock, Aakanksha Khandelwal

Clin Cancer Res· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing the toxicity of cancer therapy: recognizing needs, taking action.
Charles S Cleeland, Jeff D Allen, Samantha A Roberts, Joanna M Brell, Sergio A Giralt, Virginia E Kwitkowski

Nat Rev Clin Oncol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA approval summary: temsirolimus as treatment for advanced renal cell carcinoma.
Virginia E Kwitkowski, Tatiana M Prowell, Amna Ibrahim, Ann T Farrell, Robert Justice

Oncologist· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity.
Nilofer S Azad, Edwin M Posadas, Virginia E Kwitkowski, Seth M Steinberg, Lokesh Jain

J Clin Oncol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective analysis of imatinib-induced c-KIT modulation in ovarian cancer: a phase II clinical study with proteomic profiling.
Edwin M Posadas, Virginia Kwitkowski, Herbert L Kotz, Virginia Espina, Lori Minasian

Cancer· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer.
Edwin M Posadas, Meghan S Liel, Virginia Kwitkowski, Lori Minasian, Andrew K Godwin

Cancer· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical applications of genetics in sporadic cancers.
Virginia E Kwitkowski, Janine R Daub

Semin Oncol Nurs· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis